Clinical Trial: MRI-guided Ventricular Tachycardia Ablation in Patients With Structural Heart Disease

U.S., Oct. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07896980) titled 'MRI-guided Ventricular Tachycardia Ablation in Patients With Structural Heart Disease' on Oct. 20.

Brief Summary: Ventricular tachycardia (VT) is a life-threatening heart rhythm disorder that frequently occurs in patients with structural heart disease, such as ischemic or non-ischemic cardiomyopathy. In these patients, VT usually arises from re-entrant circuits within or around scar tissue in the heart muscle. Catheter ablation, which uses radiofrequency energy to eliminate the abnormal tissue responsible for VT, is an established treatment. However, its long-term success rate remains modest (about 40-60%), partly because convention...